Literature DB >> 17659814

Ligand screening system using fusion proteins of G protein-coupled receptors with G protein alpha subunits.

Hinako Suga1, Tatsuya Haga.   

Abstract

G protein-coupled receptors (GPCRs) constitute one of the largest families of genes in the human genome, and are the largest targets for drug development. Although a large number of GPCR genes have recently been identified, ligands have not yet been identified for many of them. Various assay systems have been employed to identify ligands for orphan GPCRs, but there is still no simple and general method to screen for ligands of such GPCRs, particularly of G(i)-coupled receptors. We have examined whether fusion proteins of GPCRs with G protein alpha subunit (Galpha) could be utilized for ligand screening and showed that the fusion proteins provide an effective method for the purpose. This article focuses on the followings: (1) characterization of GPCR genes and GPCRs, (2) identification of ligands for orphan GPCRs, (3) characterization of GPCR-Galpha fusion proteins, and (4) identification of ligands for orphan GPCRs using GPCR-Galpha fusion proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659814     DOI: 10.1016/j.neuint.2007.06.006

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  5 in total

Review 1.  Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets.

Authors:  Xiao-long Tang; Ying Wang; Da-li Li; Jian Luo; Ming-yao Liu
Journal:  Acta Pharmacol Sin       Date:  2012-02-27       Impact factor: 6.150

Review 2.  Deorphanization of novel peptides and their receptors.

Authors:  Akihiko Ozawa; Iris Lindberg; Bryan Roth; Wesley K Kroeze
Journal:  AAPS J       Date:  2010-05-06       Impact factor: 4.009

3.  Measurement of thyroid stimulating immunoglobulins using a novel thyroid stimulating hormone receptor-guanine nucleotide-binding protein, (GNAS) fusion bioassay.

Authors:  M Pierce; R Sandrock; G Gillespie; A W Meikle
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

4.  CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor heterodimer.

Authors:  Geraldine Parenty; Shirley Appelbe; Graeme Milligan
Journal:  Biochem J       Date:  2008-06-01       Impact factor: 3.766

Review 5.  Molecular properties of muscarinic acetylcholine receptors.

Authors:  Tatsuya Haga
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2013       Impact factor: 3.493

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.